-
Anavex Life Sciences Joins The Club Of Stocks Moving Higher On News Of Alzheimer's Research
Wednesday, October 5, 2016 - 12:38pm | 412Read More...Wall Street analysts have shown a bullish sentiment towards pharmaceutical and healthcare companies that focus on the treatment of Alzheimer's disease. A few days ago, BMO Capital Market's hosted a conference call with Dr. Dennis Selkoe, a leading Alzheimer's diseases researcher....
-
Anavex Life Sciences Erases 5% Gain, Company Released Of Encouraging Preclinical Results
Thursday, February 25, 2016 - 1:58pm | 248Read More...Shares of Anavex Life Sciences Corp. (NASDAQ: AVXL), a clinical-stage biopharmaceutical company that focuses on therapies for Alzheimer's Disease, were trading higher by more than 5 percent Thursday morning - only to give up gains and trade flat by the afternoon. Investors and traders were...
